Loading icon
Categories
Bioinformatics
2
Genetics
10
Art and Literature
3
Tutorials
6
Multiple Sclerosis
5
Omics
2
Trending post
1
Fewer Infusions, Same Protection? Rethinking Ocrelizumab Dosing in Multiple Sclerosis
Genetics
Fewer Infusions, Same Protection? Rethinking Ocrelizumab Dosing in Multiple Sclerosis

25, Aug 2025

2
Fewer Infusions, Same Protection? Rethinking Ocrelizumab Dosing in Multiple Sclerosis
Genetics
Ocrelizumab Rewrites the T-Cell Script in Early Multiple Sclerosis

25, Aug 2025

3
B Cells in the Spotlight: How Ocrelizumab Is Changing the Story of Multiple Sclerosis
Genetics
B Cells in the Spotlight: How Ocrelizumab Is Changing the Story of Multiple Sclerosis

23, Aug 2025

4
A Genetic Brake on Multiple Sclerosis: How SLC9A9 Shapes Treatment Response
Genetics
A Genetic Brake on Multiple Sclerosis: How SLC9A9 Shapes Treatment Response

22, Aug 2025

5
Why Some MS Patients Bounce Back Too Fast: New Clues from African Ancestry Immune Responses
Genetics
Why Some MS Patients Bounce Back Too Fast: New Clues from African Ancestry Immune Responses

22, Aug 2025

Categories:
Genetics
Could Our Genes Hold the Key to Safer MS Treatments? Exploring the Promise of Pharmacogenomics
Genetics
Could Our Genes Hold the Key to Safer MS Treatments? Exploring the Promise of Pharmacogenomics

03, Apr 2025

Personalized MS Treatment: Will Our Genes Lead the Way?
Genetics
Personalized MS Treatment: Will Our Genes Lead the Way?

05, Apr 2025

Decoding MS Treatment: Can Our Genes Predict How We'll Respond to Interferon-beta?
Genetics
Decoding MS Treatment: Can Our Genes Predict How We'll Respond to Interferon-beta?

06, Apr 2025

Decoding MS Treatment Response: A Look at the Pharmacogenomics of Interferon-Beta and Glatiramer Acetate
Genetics
Decoding MS Treatment Response: A Look at the Pharmacogenomics of Interferon-Beta and Glatiramer Acetate

07, Apr 2025